ANNA L CYMBALUK

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology SAN DIEGO, CA NPI 1043674849

General Payments — all program years on this page

$767.18

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $452.19 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $452.1921

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
DEXCOM, INC. $138.177
ABBVIE INC. $114.375
Azurity Pharmaceuticals, Inc. $64.333
TOLMAR, INC. $30.501
Eton Pharmaceuticals, Inc. $25.261
Tandem Diabetes Care, Inc. $21.581
Novo Nordisk AS $20.501
SANOFI-AVENTIS U.S. LLC $18.981
PFIZER INC. $18.501

By program year

Program yearAmountRecords
2023 $314.9915
2024 $452.1921

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097471784 Novo Nordisk Inc $20.50 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103524756 ABBVIE INC. $22.42 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103524758 ABBVIE INC. $29.23 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103524760 ABBVIE INC. $23.56 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103524762 ABBVIE INC. $20.92 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103524764 ABBVIE INC. $18.24 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108021322 Eton Pharmaceuticals, Inc. $25.26 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131947500 PFIZER INC. $18.50 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134004705 Azurity Pharmaceuticals, Inc. $18.36 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134004707 Azurity Pharmaceuticals, Inc. $22.29 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134004709 Azurity Pharmaceuticals, Inc. $23.68 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138711076 Tolmar, Inc. $30.50 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138751665 Tandem Diabetes Care, Inc. $21.58 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139859924 SANOFI-AVENTIS U.S. LLC $18.98 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153281406 Dexcom, Inc. $17.51 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153281409 Dexcom, Inc. $0.79 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153281413 Dexcom, Inc. $24.09 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153281417 Dexcom, Inc. $17.68 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153281419 Dexcom, Inc. $23.57 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153281421 Dexcom, Inc. $20.09 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153281423 Dexcom, Inc. $34.44 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.